RE:RE:RE:RE:RE:RE:RE:RE:TLT Filling Up With CashHi consultant99, my opinion is no to one partnership, why, because we have St. Michael's Lee Ka Shing plus Vera Madzarevic to guide us and possible suggestions from the FDA. Several partnerships leaves Theralase in total control of the network to be established. No to buyout and no to one company taking a major part of the revenue. Theralase did all the research & development of the treatment and I just can't see them giving out your suggested gift. Remember this is only the 1st of a large list of cancer indications they will conquer. Many large pharmaceutical companies will suffer continuing losses of revenue so Theralase can lessen the loss to them by including them in the network to be established, this is common in many different large manufacturers. I've personally seen competitors have joint operations with 50/50 ownership and anything in between 10/90. Look at the auto industry! If Theralase does go this route there could be a day when they will buy segments of current cancer pharmaceutical supply chain. Anything is possible and on the table to happen.
As for me I will wait and see how they approach their first success story.